Milestones & Awards
  • 2023.5

    AsymBio’s Center of Biological Technology and Innovation was established

  • 2022.11

    Commercial production facilities for antibodies and bioconjugates were launched

  • 2022.7

    Plasmid and mRNA pilot plant in Suzhou was launched

  • 2021.11

    The capability for laboratory R&D projects for plasmids and mRNAs was established

  • 2021.5

    The capability for laboratory development of bioconjugates was established

  • 2020.12

    The capability for early-stage development and production of antibodies was established

  • 2019.1

    AsymBio was founded


Pharmaceutical Service Provider of the Year (CXO), 3rd Biopharmaceutical Industry Ranking

TOP 10 CGT CDMO with the Most Potential, CGCS 2023

CDMO of the Year, CGT Industry Stars 2023

Future Top 100 CDMOs in Medical Care

Top 10 CGT CDMO with the Most Potential, China Pharmaceutical Industry List